Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 13D/13G Filings for MBX Biosciences, Inc. Common Stock (MBX)

Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 13D and 13G filings for MBX Biosciences, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-09-20
10:13 am
Purchase		 2024-09-13 13G MBX Biosciences, Inc. Common Stock
MBX		 Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 1,790,122
5.620%		 1,790,122increase
(New Position)		 Filing